Artificial Intelligence Programs News Today

WOBURN, Mass., Dec. 11, 2023 /PRNewswire/ -- HanAll Biopharma's partner NurrOn Pharmaceuticals Inc., a clinical-stage biopharmaceutical company dedicated to developing novel, targeted therapeutics for the treatment of Parkinson's disease (PD) and other Nurr1-related human disorders, is pleased to announce the appointment of Dr. Almira Chabi, MD, EGMP to its Board of Directors, effective November 24, 2023. Dr. Chabi...

A new study adds 'environmental stability' to the list of AI industry concerns.

The warning comes as the United States is also exploring their own plans to harness AI technology for its own benefit.

Senate Majority Leader Chuck Schumer has announced that the Senate will seek to address national security and education concerns about artificial intelligence (AI) programs, such as ChatGPT.

Senate Majority Leader Chuck Schumer has announced that the Senate will seek to address national security and education concerns about artificial intelligence (AI) programs, such as ChatGPT.

SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief...

/PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer...

/PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today the appointment of Almira Chabi, M.D. as Chief Medical Officer and Chief Development Officer...

HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer - read this article along with other careers information, tips and advice on BioSpace

We are in the midst of a moment where AI is under the microscope, with policymakers picking apart AI contributions and demanding that AI meet high standards of performance. However, I fear in the drive to make AI better, the perfect may become the enemy of the good.